The prevalence of premalignant gastric lesions in asymptomatic patients: Predicting the future incidence of gastric cancer

https://doi.org/10.1016/j.ejca.2010.12.012Get rights and content
Under an Elsevier user license
open access

Abstract

Background

Helicobacter pylori is the main risk-factor for gastric cancer through a cascade from gastritis through atrophic gastritis (AG), intestinal metaplasia (IM), dysplasia (DYS) to malignancy. The presence of these lesions in the general population predicts the gastric cancer incidence in the coming decades. Prevalence data are mostly obtained from serological studies and endoscopy data in symptomatic patients.

Aim

To investigate the prevalence of H. pylori infection and its related gastric changes in asymptomatic subjects.

Methods

383 Patients undergoing routine colonoscopy were included. All subjects underwent upper GI endoscopy and completed the Gastrointestinal Symptom Rating Scale (GSRS). Biopsies were taken from antrum and corpus.

Results

H. pylori infection was present in 22%. Non-Caucasian subjects had a significantly higher H. pylori prevalence (p < 0.001). AG, IM and DYS were together found in 9.3% of subjects. Subjects with AG, IM or DYS were significantly older (p < 0.001). No differences were found with respect to gender, presence of GI symptoms as scored by GSRS, lifestyle and medication use.

Conclusions

The prevalence of premalignant gastric lesions is considerable in general Western population with increasing age as the main risk factor. One time screening for premalignant lesions at the age of 60 years is a reasonable strategy since the numbers found imply that gastric cancer will remain a prevalent disease.

Keywords

H. pylori gastritis
Atrophic gastritis
Intestinal metaplasia
Risk factors
Gastric cancer
Screening

Cited by (0)

d

Present address: Department of Gastroenterology and Hepatology, Kennemer Gasthuis, Haarlem, The Netherlands.

e

Present address: Department of Pathology, Saint Lucas Andreas Hospital, Amsterdam, The Netherlands.

f

Present address: Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, The Netherlands.